baber/WOPTO huggingface dataset:
Patent NZ-580276-A (NZ)
Title: A method of deploying a hydroelectric tidal turbine through the base of a vessel
Inventor: IVES JAMES
IPC: E02D27/52
Filed: 2008-04-11
Abstract: Disclosed is a method of deploying a hydroelectric turbine. The method includes the steps of: securing a base for the turbine beneath a vessel; securing the turbine to a support of the base which projects upwardly through the vessel; transporting the vessel to a deployment site; and releasing the base from beneath the vessel. The step of releasing the base from beneath the vessel, allows the turbine to pass through the vessel.
Patent NZ-580445-A (NZ)
Title: 5,6-DIHYDRO-1H-PYRIDIN-2-ONE COMPOUNDS useful in the treatment of hepatitis C virus
Inventor: TRAN CHINH VIET
IPC: A01N43/66
Filed: 2008-04-02
Abstract: Disclosed are 5,6-dihydro-1H-pyridin-2-one compounds of formula I and a process for their preparation which are useful in treating or preventing a hepatitis C virus infection. An example of a compound of formula I is (rac-di-exo)-N- { 3-[3-(4-fluoro-benzyl)-6-hydroxy-4-oxo-3-azatricyclo[6.2.1.02,7]undec-5-en-5-yl]-1,1-dioxo-1,4-dihydro-1[lambda]6-benzo[1,2,4]thiadiazin-7-yl} -methanesulfonamide.
Patent NZ-582661-A (NZ)
Title: Method for modulating gpr119 g protein-coupled receptor and selected compounds
Inventor: WACKER DEAN A
IPC: A61K31/454
Filed: 2008-07-16
Abstract: Disclosed the use of a compound of formula (I) or (IA) and an additional therapeutic agent in the manufacture of a medicament for treating or preventing a disease or disorder selected from diabetes, hyperglycemia, impaired glucose tolerance, insulin resistance, hyperinsulinemia, retinopathy, neuropathy, nephropathy, delayed wound healing, atherosclerosis and its sequelae, abnormal heart function, myocardial ischemia, stroke, Metabolic Syndrome, hypertension, obesity, dislipidemia, dyslipidemia, hyperlipidemia, hypertriglyceridemia, hypercholesterolemia, low HDL, high LDL, non-cardiac ischemia, infection, cancer, vascular restenosis, pancreatitis, neurodegenerative disease, lipid disorders, cognitive impairment and dementia, bone disease, HIV protease associated lipodystrophy and glaucoma, Also disclosed is a compound of formula (I) where the substituents are as disclosed in the specification examples of compounds are: 1-(4-(oxazol-2-yl)phenyl)-4-(1-(5-propylpyrimidin-2-yl)piperidin-4-yloxy)pyridin-2(1H)-one and isopropyl 4-(1-(4-(1H-1,2,4-triazol-1-yl)phenyl)-2-oxo-1,2-dihydropyridin-4-yloxy)piperidine-1-carboxylate.
Patent NZ-591199-A (NZ)
Title: A wave electrical power plant with a float connected by a cable to a linear generator via a parabolic curved circular wire guide
Inventor: LEIJON MATS
IPC: F03B13/18
Filed: 2008-08-26
Abstract: Disclosed is a wave power electrical power generation unit with a guiding collar that allows a wave driven float to be off axis from the generator centre-line. The wave-power unit comprises a floating body for floating on the sea and an electric linear generator having a stator and translator reciprocating along a centre axis. The stator is anchored to the seabed and the translator being connected to the floating body by a flexible cable. The wave-power unit includes a curved guiding device rigidly connected to the generator housing, where the cable passes through a lower opening and an upper opening of the guiding device. The portion of the cable momentarily being located between the openings is defined as the guided portion. The lower opening is arranged so that the guided portion adjacent the lower opening is aligned with said centre-line axis and the upper opening is arranged so that the guided portion adjacent the upper opening forms an angle with the centre axis.
Patent NZ-594020-A (NZ)
Title: Case and stand for a portable electronic device which allows rotation of the device
Inventor: GALLAGHER KEVIN
IPC: F16M11/06
Filed: 2011-07-12
Abstract: A case for a portable electronic device comprises a base configured to sit on a working surface and a holder configured to hold the portable electronic device. A support extends between and is connected to the holder and the base. The support is configured to support the holder in an elevated position relative to the base. A rotational mechanism pivotally connects the holder to the support. The rotational mechanism is configured to allow the holder to rotate in one or more directions relative to the support. The base includes at least one channel, the channels being configured to receive an edge of the holder.
Patent NZ-595987-A (NZ)
Title: A novel formulation of diclofenac
Inventor: DODD AARON
IPC: B01J2/00
Filed: 2010-04-23
Abstract: 595987 The present disclosure relates to methods for producing particles of diclofenac using dry milling processes as well as compositions comprising diclofenac, medicaments produced using diclofenac in particulate form and/or compositions, and to methods of treatment of an animal, including man, using a therapeutically effective amount of diclofenac administered by way of said medicaments.
Patent NZ-598046-A (NZ)
Title: Article distribution and sorting system
Inventor: SANCHEZ RUDY
IPC: B65G47/14
Filed: 2010-07-09
Abstract: 598046 Disclosed is a radial distribution system for distributing product. The system has a base member for receiving product for distribution to a number of conveyors, a sloped side wall that substantially surrounds the base member to allow for product accumulation, a number of gate members radially-spaced around the base member in the sloped side wall and configured to move between an open position and a closed position, and a vibration member configured to vibrate the base member so that product received on the base member moves in a circular manner around the base member.
Patent NZ-605487-A (NZ)
Title: Wireless target system
Inventor: CEDERWALL PER
IPC: F41G3/26
Filed: 2011-06-29
Abstract: Disclosed is a wireless target system unit (1) for a weapon effect simulation system. The unit (1) includes a radio transmitter and receiver (2) arranged for communication with a control system. The wireless target system unit ( 1 ) further has a laser receiver (6) arranged for receiving laser light from an attacking system. The wireless target system unit (1) includes two retro-reflecting prisms (3, 4) arranged to retro-reflect an incident laser light from an attacking system. The laser light has a laser pulse pattern with a first laser lobe, a second laser lobe and a third laser lobe. Each reflecting centre of the retro-reflecting prisms (3, 4) and a sensor centre of the laser receiver (6) are mounted such that they form an isosceles triangle. The distance between the reflecting centre of each the retro reflecting prism (3, 4) and the sensor centre of the laser receiver (6) are equal. The isosceles triangle form of the reflecting centres of the retro-reflecting prisms (3, 4) and the sensor centre of the laser receiver (6) is arranged to correspond with the laser pulse pattern.
Patent NZ-609310-A (NZ)
Title: Puffed cheese product and process for making same
Inventor: STROMOTICH GREG
IPC: A23L5/30
Filed: 2011-09-13
Abstract: Disclosed is a method for making a puffed cheese product comprising: providing a precursor cheese having a fat content of between substantially 10% and 45% (w/w) and a moisture content of between substantially 10% and 80% (w/w); forming the precursor cheese into pieces suitably sized for processing and for yielding a puffed cheese product that is of a desired configuration and size; cheese pieces to flow freely relative to one another; chilling the precursor cheese pieces; subjecting the cheese pieces to microwave irradiation under vacuum to cause the precursor cheese pieces to become partially dehydrated and puffed; discontinuing microwave irradiation and reducing the vacuum; and, reintroducing the puffed cheese pieces to atmospheric pressure.
Patent NZ-612470-A (NZ)
Title: Sex discernment by real-time pcr in coho salmon
Inventor: MARTINEZ HERNANDEZ ALEXIS IVÁN
IPC: C12Q1/68
Filed: 2011-12-09
Abstract: Patent No. 612470 Disclosed is a method for discerning sex through the use of real-time polymerase chain reaction (PCR) in coho salmon (Oncorhynchus kisutch) CHARACTERIZED in that it comprises the following steps: a) extracting deoxyribonucleic acid (DNA) from coho salmon either from biological or solid or semisolid matrices, such as muscle, fin, gill or the like, or fluids, such as total blood, plasma and serum; b) amplifying the DNA eluate from step (b) by the use of polymerase chain reaction (PCR), in real-time format, using the fluorescent probe pCsex1 which corresponds to the sequence (FAM) 5´-CCTGTGTATACTTGGGAGCGGTAAGCC-3´ and a mixture of primers comprising the CSex2s primer: 5´-CATTATATTTGGCTGAAGAGTCAGTG-3´ and the CSex2r primer: 5´-GGAACAGATGGAGCGGTCTTC-3´; c) identifying the presence of the sequence CATTATATTTGGCTGAAGAGTCAGTGTTCTGCTTGTATTAATATAATATAGA GCTTGAATTTAGACTTGAATTCTCACAGTTGGAGGTCAGTTTAGTTATGAAT TAAACCTGTGTATACTTGGGAGCGGTAAGCCATGTGCCCATTTACAAAGTCT GACCAGAGAAGACCGCTCCATCTGTTCC, as a fluorescence signal, in the amplification resulting from step (c), assigning to the presence of said fluorescence signal the determination of male sex in coho salmon, whose DNA was amplified, and to the absence of said fluorescence signal, the determination of female sex in coho salmon, whose DNA was amplified. Also disclosed is a mixture of primers for discerning sex through the use of real-time polymerase chain reaction (PCR) in coho salmon (Oncorhynchus kisutch), CHARACTERIZED in that it comprises the synthetic sequences CSex2s: 5´-CATTATATTTGGCTGAAGAGTCAGTG-3´ and CSex2r: 5´-GGAACAGATGGAGCGGTCTTC-3´.
Patent NZ-615623-A (NZ)
Title: Chemical composition with hydrogen peroxide and a nanoemulsion of long-chained alcohols
Inventor: GRASCHA PIERRE BRUNO
IPC: A61P31/02
Filed: 2011-03-02
Abstract: Provided is a nanoemulsion composition comprising a peroxide compound and long-chained alcohols. The preferred peroxide compound is hydrogen peroxide. The composition may comprise: •at least one peroxide containing compound present in a range to give from about 0.1 to about 4 wt./wt. % released hydrogen peroxide; •at least one organic acid present in a concentration from about 0.01 to about 5 wt./wt. % for adjusting a pH of the formulation in a range from about pH 1 to about pH 4; •at least one long-chained (C9 to C22) aryl and/or alkylalcohol, present in a concentration from about 0.1 to about 20 wt./wt. %; •at least one emollient present In a concentration from about 0.1 to about 40 wt./wt. %; •water present in an amount sufficient to obtain a nanoemulsion; •at least one nonionic and/or anionic emulsifier present in a concentration from 10 about 0.1 to about 20 wt./wt. %. The composition is useful as a disinfectant that can be applied to skin.
Patent NZ-624119-A (NZ)
Title: Aerosol-generating article for use with an aerosol-generating device
Inventor: ZUBER GÉRARD
IPC: A24F40/46
Filed: 2012-12-28
Abstract: An aerosol-generating article (10) comprises: an aerosol-forming substrate (20);a support element (30) located immediately downstream of the aerosol-forming substrate (20); an aerosol-cooling element (40) located downstream of the support element (30); and an outer wrapper(60) circumscribing the aerosol-forming substrate (20), the support element(30) and the aerosol-cooling element (40). The support element (30) abuts the aerosol-forming substrate (20). The aerosol-forming substrate (20) is penetrable by a heating element (110) of an aerosol-generating device(120).
Patent NZ-624542-A (NZ)
Title: Medicament for therapeutic treatment and/or improvement of sepsis
Inventor: TSURUTA KAZUHISA
IPC: C12N15/09
Filed: 2012-11-14
Abstract: Disclosed is the use of thrombomodulin in the manufacture of a medicament for therapeutic treatment and/or improvement of sepsis, wherein the sepsis is severe and is accompanied with one or more organ dysfunctions, and wherein a value of International Normalized Ratio (INR) of a plasma specimen is more than 1.4. Also disclosed is the use of thrombomodulin in the manufacture of a medicament for decreasing the mortality of patients with sepsis, wherein the sepsis is severe and is accompanied with one or more organ dysfunctions, and wherein a value of International Normalized Ratio (INR) of a plasma specimen is more than 1.4.
Patent NZ-626618-A (NZ)
Title: Hydroxamic acid derivatives and uses thereof
Inventor: CHEN YU
IPC: C07D235/30
Filed: 2013-01-31
Abstract: The disclosure relates to a class of hydroxamic acid compounds of Formula (I), The disclosure also relates to their use as alkylating agents and/or inhibitors of the HDAC pathway and in the treatment of a neoplastic disease and immune diseases, such as cancer.
Patent NZ-627354-A (NZ)
Title: Organic emulsion comprising dha and epa
Inventor: VOELKER KARL MANFRED
IPC: A23L29/10
Filed: 2013-01-11
Abstract: Disclosed is an emulsion comprising 5 - 40 wt-%, based on the total weight of the emulsion, of docosahexaenoic acid (DHA) and eicosapentaenoic acid (EPA) oils; 3 - 15 wt-%, based on the total weight of the emulsion, of fish gelatine; 1 - 5 wt-%, based on the total weight of the emulsion, of ascorbic acid and/or citric acid; 0.5 - 5 wt-%, based on the total weight of the emulsion, of sodium hydroxide (NaOH); 35 - 90.5 wt-%, based on the total weight of the emulsion, of water; 150 ppm — 1000 ppm of at least one tocopherol / vitamin E derivative, wherein the tocopherol is chosen from the groups consisting of dl-alpha-tocopherol, alpha-tocopherol, beta-tocopherol, gamma-tocopherol and delta-tocopherol; and 1000 ppm — 5000 ppm of rosemary extract; whereby the pH value of the emulsion is between 5 and 7, and the emulsion is essentially free of ascorbyl palmitate. Also disclosed is the use of an emulsion as defined above in food, feed or personal care products.
Patent NZ-630427-A (NZ)
Title: Crystals of laquinimod sodium and improved process for the manufacture thereof
Inventor: FRISTEDT ULF TOMAS
IPC: G01N33/15
Filed: 2014-03-14
Abstract: The present application provides subject-matter related to a mixture of crystalline laquinimod sodium particles, wherein (i) 90% or more of the total amount by volume of the laquinimod sodium particles have a size of less than 40 μιη or (ii) 50% or more of the total amount by volume of the laquinimod sodium particles have a size of less than 15 μιη and wherein one or more of further requirements are fulfilled with regard to bulk density, tapped density and the amount of certain impurities. The present application also provides a pharmaceutical composition comprising an amount of laquinimod and at least one of BH-3-HLAQ, MCQ, MCQCA, MCQME, NEA, and MCQEE. The subject invention also provides processes for preparing BH-3-HLAQ, MCQ, MCQCA, MCQME, MCQEE, and compounds prepared by said processes. Further provided is a process for testing whether a sample of laquinimod contains an undesirable impurity. Further provided are processes for (a) preparing a validated pharmaceutical composition comprising laquinimod, (b) distributing a validated batch of a pharmaceutical composition comprising laquinimod, (c) validating a batch of a pharmaceutical product containing laquinimod and (d) preparing a packaged pharmaceutical composition comprising laquinimod, each comprising determining the amount of at least one of BH-3-HLAQ, MCQ, MCQCA, MCQME, NEA, and MCQEE in a sample or batch. The subject invention further provides use of BH-3-HLAQ, MCQ, MCQCA, MCQME, MCQEE as a reference standard to detect trace amounts of the impurity in a pharmaceutical composition comprising laquinimod. Finally, the subject invention provides methods of determining the concentration of BH-3-HLAQ, MCQ, MCQCA, MCQME, MCQEE, 5-HLAQ, SPIRO-LAQ or 3 H-LAQ in a pharmaceutical composition comprising laquinimod.
Patent NZ-708272-A (NZ)
Title: Pharmaceutical composition with improved bioavailability
Inventor: SANDHU HARPREET K
IPC: A61K9/10
Filed: 2014-01-20
Abstract: The invention relates to solid dispersions of poorly water soluble compounds, in particular 4-{ [(2R,3S,4R,5S)-4-(4-chloro-2-fluorophenyl)-3-(3-chloro-2-fluorophenyl)-4-cyano-5-(2,2-dimethylpropyl)-pyrrolidine-2-carbonyl]amino} -3-methoxy-benzoic acid, formed by solvent co-precipitation or spray drying with a stabilising polymer, resulting in improved bioavailability, safety and tolerability of said compounds, and where in the stabilising polymer is poly(methacrylic acid)-co-methyl methacrylate (EUDRAGITR L-100), poly(methacrylic acid)-co-methyl methacrylate (Eudragit L100-55) or poly(vinylpyrrolidone-co-vinyl acetate) (6+4).
Patent NZ-709587-A (NZ)
Title: Method for preparing cyclopropane derivatives
Inventor: KISS ELEONORA
IPC: C07D321/10
Filed: 2011-11-10
Abstract: Disclosed herein is a method for the preparation of a cyclopropane compound of formula A where the substituents are as defined herein comprising the step of coupling a compound of formula (10) or (12) with a compound of formula B-H under Mitsunobu conditions.
Patent NZ-709740-A (NZ)
Title: Processing materials with ion beams
Inventor: MEDOFF MARSHALL
IPC: C10G19/00
Filed: 2009-06-17
Abstract: The disclosure relates to amethod of changing a molecular structure of a hydrocarbon-containing material, the method comprising: producing an ion beam comprising a first distribution of ion energies having a full width at half maximum of W; adjusting the energies of at least some of the ions to produce a second distribution of ion energies in the ion beam having a full width at half maximum of more than W; and exposing the hydrocarbon-containing material to the adjusted ion beam; wherein adjusting is based on a thickness of the hydrocarbon-containing material; and wherein the hydrocarbon-containing material comprises one or more of: oil sand, oil shale, tar sand, bitumen, and coal.
Patent NZ-712421-A (NZ)
Title: Peptide compound having an activating action on glp-1 receptors and gip receptors
Inventor: ASAMI TAIJI
IPC: C07K14/605
Filed: 2014-05-27
Abstract: The present invention provides a novel peptide compound having an activating action on GLP-1 and GIP receptors and use of the peptide compound as a medicament. Specifically, a peptide containing a partial sequence represented by the formula (I) or a salt thereof and a medicament comprising the same are provided. Formula (I) is P1-Tyr-Aib-Glu-Gly-Thr-alphaMePhe-Thr-Ser-Asp-Tyr-A11-A12-A13-Leu-Asp-A16-A17-Ala-Gln-A20-Glu-Phe-Val-Lys-Trp-Leu-Leu-Lys-A29 where each symbol is as defined herein.
Patent NZ-716615-A (NZ)
Title: Automated demand response energy management system
Inventor: ROMBOUTS JAN-WILLEM
IPC: H02J3/14
Filed: 2012-12-12
Abstract: Disclosed is a method of maximizing a power flexibility of an energy load. the method includes receiving load constraints indicating conditions under which the energy load should be operated, receiving a set of control parameters and possible values that control operation of the energy load and affect power usage of the energy load and receiving a computer model of the energy load. the model outputs the power usage of the energy load in response to changes in inputs to the model. A value function is then determined having a term indicating a change in energy usage as a function of the control parameters for the energy load during time intervals of a time period. The value function is then maximised using the computer model, the load constraints, and the control parameters. A subset of the control parameters is then output resulting from maximizing the value function. The subset is able to control operation of the energy load within the load constraints while maximizing the change in energy usage.
Patent NZ-722129-A (NZ)
Title: Construction of a building structure with a weatherproof join
Inventor: PANENI CARLO
IPC: E04D3/38
Filed: 2015-01-22
Abstract: There is disclosed a method of constructing a building structure which includes a pair of adjacent building modules and a weatherproof join therebetween, the method comprising the steps of: providing each building module with a respective guide; locating the building modules such that they are adjacent and a gap or junction is formed therebetween; effecting interengagement between said guides and opposite edge portions of a weatherproof bridging element; and, with the guides and edge portions thus interengaged, advancing the bridging element along the guides such that the bridging element overlies the gap or junction. This mitigates the risks involved with having construction workers exposed to heights, the use of scaffolds, and reduces building materials such as fasteners used on traditional methods sealing a join.
Patent NZ-722440-A (NZ)
Title: Novel anti-presepsin antibody
Inventor: SHIRAKAWA KAMON
IPC: C12N15/09
Filed: 2015-02-25
Abstract: The present invention addresses the problem of providing a novel monoclonal antibody having excellent reactivity with presepsin and being suited to measuring presepsin in a specimen, or an antigen-binding antibody fragment of said antibody. Provided is an anti-presepsin antibody that specifically recognizes an epitope comprising a SEQ ID NO: 1 amino acid sequence, or an antigen-binding antibody fragment of said antibody.
Patent NZ-735767-A (NZ)
Title: Setting accelerator for a tile adhesive blend
Inventor: ROMEGIALLI GIANLUCA
IPC: C04B22/08
Filed: 2016-04-29
Abstract: The application relates to the use of a powder comprising calcium nitrate as a setting accelerator for a tile adhesive blend, wherein a powder comprising calcium nitrate, and optionally also comprising a nitrate salt different than the calcium nitrate, specifically potassium or ammonium nitrate, with at least 70 wt% of the powder having a particle size of between 0.01 mm and 1 mm, is used as the setting accelerator. The application furthermore relates to a process for producing such a setting accelerator comprising, in one possible embodiment, the step of cutting or grinding prills and/or granules comprising the calcium nitrate and optionally the different nitrate salt, and in another embodiment, a spray drying process, resulting into the setting accelerator. The application also relates to a tile adhesive blend comprising at least a cement, sand and a such setting accelerator.
Patent NZ-743419-A (NZ)
Title: Three-dimensional polymer networks with channels situated therein
Inventor: KLAPPROTH HOLGER
IPC: G01N33/543
Filed: 2016-12-16
Abstract: The disclosure provides three-dimensional crosslinked polymer networks comprising one or more channels extending from the surface and/or near the surface of the network into the interior of the network, arrays comprising the networks, processes for making the networks, and uses of the networks and arrays. The network comprises at least 5 channels, that converge at a point in the interior of the network such that the lateral distance between the channels decreases from the surface toward the point in the interior. The networks of the disclosure allow for fast hybridization of analyte.
Patent NZ-744322-A (NZ)
Title: Hybrid led / photoluminescent signs
Inventor: ROGER MCKENZIE
IPC: H05B45/50
Filed: 2018-07-13
Abstract: A hybrid photoluminescent / light emitting diode sign includes a number of photoluminescent elements and a number of light emitting diodes (LEDs) arranged to emit light onto the one or more photoluminescent elements, thereby exciting or charging the photoluminescent elements. The LEDs are included in an electronic circuit powered from an AC source, such as a mains electrical supply. The circuit includes one or more transient suppression components selected from at least two resistors and at least two capacitors (R1, R2, C1, C2). The transient suppression components are arranged to suppress transients in power received from the AC power supply to prevent the transients from damaging the electronic circuitry. A rectifier receives transient-suppressed power and passes substantially unsmoothed rectified power to a DC circuit portion including the LEDs. The DC circuit portion may be free of electrolytic capacitors. The resulting sign protects circuit elements from surges or transients and has improved lifetime. The sign may, for example, be an emergency sign.